COVID-19-associated Pulmonary Aspergillosis: A Case Series

BACKGROUND: With the development of coronavirus disease-2019 (COVID-19) pandemic, there is also increased risk of multiple secondary infections either disease- or drug-related. It includes many bacterial as well as invasive fungal infections. PATIENTS AND METHODS: There was suspicion of invasive pul...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Khushboo, Kujur, Rash, Sharma, Saurabh, Kumar, Nishith, Ray, Manoj Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492747/
https://www.ncbi.nlm.nih.gov/pubmed/36213710
http://dx.doi.org/10.5005/jp-journals-10071-24314
Descripción
Sumario:BACKGROUND: With the development of coronavirus disease-2019 (COVID-19) pandemic, there is also increased risk of multiple secondary infections either disease- or drug-related. It includes many bacterial as well as invasive fungal infections. PATIENTS AND METHODS: There was suspicion of invasive pulmonary aspergillosis (IPA) infection in COVID-19 patients who were critically ill and had acute respiratory distress syndrome (ARDS). We did radiological evaluation and galactomannan assay in these patients. RESULT: We have diagnosed COVID-19-associated pulmonary aspergillosis (CAPA) in these patients and started antifungal treatment with voriconazole in all of these COVID-19 patients. CONCLUSION: It is very important to report such cases, so that healthcare professionals and authorities related to healthcare will be aware of and may also prepare for the increasing burden of this complication. We describe a case series of CAPA infection. HOW TO CITE THIS ARTICLE: Sharma K, Kujur R, Sharma S, Kumar N, Ray MK. COVID-19-associated Pulmonary Aspergillosis: A Case Series. Indian J Crit Care Med 2022;26(9):1039–1041.

Ejemplares similares